KZIA
Kazia Therapeutics Ltd
9.30$
-2.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q2 24 | Q3 24 | Q4 24 | Q2 25 | Q3 25 | Q4 25 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -22.4% | – | – | 0.0% | -13.2% | -11.5% | +0.0% | -17.0% | -66.2% | +0.0% | +1,072.1% | |
| – | -37.4% | +82.1% | +0.0% | 0.0% | -25.7% | -23.3% | +0.0% | -44.6% | +44.8% | +0.0% | +1,317.0% | |
| – | -40.4% | – | – | 0.0% | -32.0% | -53.5% | +0.0% | +84.9% | +41.8% | +0.0% | +1,497.0% | |
| – | -40.4% | – | – | 0.0% | -32.0% | – | – | +84.9% | – | – | +1,497.0% | |
| – | +0.0% | -84.9% | +0.0% | -0.6% | -37.7% | -100.0% | – | -33.5% | – | – | +250.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.9% | – | – | 0.0% | -5.4% | -5.7% | +0.0% | -6.1% | -92.5% | +0.0% | -0.1% | |
| – | -7.7% | – | – | 0.0% | +19.2% | +65.3% | +0.0% | -31.3% | -33.9% | +0.0% | +71.4% | |
| – | -17.0% | +35.5% | +0.0% | 0.0% | +49.8% | +127.6% | +0.0% | -36.0% | -14.9% | +0.0% | +73.3% | |
| – | -70.0% | – | – | 0.0% | -80.0% | – | – | -77.8% | – | – | -75.1% | |
| – | +51.4% | -62.8% | +0.0% | 0.0% | +21.1% | +338.1% | +0.0% | +39.2% | -10.8% | +0.0% | +8.4% | |
| – | -36.6% | – | – | 0.0% | -56.3% | -290.2% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.5% | +76,395.4% | +6.0% | -99.8% | +5.2% | +69,301.7% | -99.8% | +47.8% | +95,090.5% | -99.8% | +100.9% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.